Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

23.43
Delayed Data
As of Aug 17
 +0.43 / +1.87%
Today’s Change
11.40
Today|||52-Week Range
37.69
+32.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.0011.4M
 
 
Depreciation And Amortization641.0K603.0K197.0K14.0K
 
 
 
 
 
 
Operating ExpensesGross Income---603.0K-197.0K11.4M
 
 
 
 
General Expenses20.5M19.2M19.6M18.2M
 
 
 
 
 
Other Operating Expenses0.000.000.00503.8M
 
 
Research And Development14.3M14.2M13.4M8.1M
 
 
 
 
 
Total Operating Expenses21.1M19.8M19.8M522.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.1M-19.8M-19.8M-510.7M
 
 
 
 
 
Extraordinary Credit1.2M5.1M1.0M504.0M
 
 
 
 
 
Extraordinary Charge0.000.000.00-5.6M
 
 
Interest Expense On Debt0.000.000.001.3M
 
 
Other Expenses546.0K531.0K-2.0K-2.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.3M-14.1M-18.7M-16.3M
 
 
 
 
 
Income Taxes-15.0K-26.0K-29.0K-62.0K
 
 
 
 
 
Net Income-19.3M-14.1M-18.7M-16.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS521.7K713.5K1.4M1.2M
 
 
 
 
 
Shares To Calculate EPS Diluted521.7K713.5K1.4M1.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$37.20-$19.80-$13.80-$13.19
 
 
 
 
 
EPS Diluted-$37.20-$19.80-$13.80-$13.19